Articles with the keyword: 
Genetically engineered tobacco plants used to grow anti-lymphoma vaccine
Darkfrog submitted, created time 3 months 4 weeks (www.sciam.com)
Reports in the Proceedings of the National Academy of Sciences report that an experimental vaccines has triggered the immune systems of eleven (out of sixteen) patients to attack their tumors. The patients are afflicted with what is called follicular B-cell lymphoma. Dangerous side effects? None.
The interesting part? The vaccine was grown courtesy of some genetically engineered tobacco plants.
Of course, all of the patients were also receiving chemotherapy at the time, so it may be difficult to tell which results may be attributed to the vaccine itself 
Arlen Specter's Hodgkin's disease comes back
DanyC submitted, created time 7 months 6 days (www.cnn.com)
Sen. Arlen Specter's Hodgkin's disease, which he battled in 2005, has recurred, but doctors said that its return was detected early and that Specter has an "excellent chance" of once again achieving remission, according to a statement issued Tuesday by the senator's office.
New Task: Malaria drug might inhibit some cancers
Sue Wu submitted, created time 10 months 2 weeks (www.sciencenews.org)
In the 1970s and 1980s, researchers in Tanzania distributed millions of doses of chloroquine to children as part of a 5-year malaria-prevention project. While the study yielded only mixed results against that disease, the researchers noticed a striking drop in cases of Burkitt's lymphoma, a blood cancer.
broadcast submitted, created time 1 year 6 months (jnci.oxfordjournals.org)
Addition of the anti-CD20 monoclonal antibody rituximab to chemotherapy (R-chemo) has been shown to improve response rates and progression-free survival in patients with indolent or mantle cell lymphoma. However, the impact of R-chemo on overall survival is unclear. We performed a comprehensive systematic review and meta-analysis to examine the efficacy of combined immunochemotherapy using R-chemo compared with the identical chemotherapy alone with respect to overall survival in patients with advanced indolent lymphoma or mantle cell lymphoma
Lymphomas can develop from B cells chronically helped by idiotype-specific T cells
athena submitted, created time 1 year 6 months (www.jem.org)
"B cell lymphomas have been associated with chronic infections and autoimmunity. However, most lymphomas develop in the absence of any known chronic antigenic stimulation. B cells process their highly diversified endogenous immunoglobulin and present clonally unique variable-region idiotypic (Id) peptides on their major histocompatibility complex (MHC) class II molecules to Id-specific T cells."
fiona submitted, created time 1 year 7 months (jco.ascopubs.org)
"We previously determined that intravenous administration of rituximab results in limited penetration of this agent into the leptomeningeal space. Systemic rituximab does not reduce the risk of CNS relapse or dissemination in patients with large cell lymphoma. We therefore conducted a phase I dose-escalation study of intrathecal rituximab monotherapy in patients with recurrent CNS non-Hodgkin's lymphoma (NHL). "
Obesity in Survivors of Childhood Acute Lymphoblastic Leukemia and Lymphoma
julie submitted, created time 1 year 7 months (jco.ascopubs.org)
"BMI weight category at diagnosis, rather than type of CNS treatment received, predicted adult weight in long-term survivors of childhood hematologic malignancies. "
Study Examines Second Cancer Risk Among Hairy Cell Leukemia Survivors
drunkard submitted, created time 1 year 9 months (www.sciencedaily.com)
Hairy cell leukemia is a malignancy of a type of white blood cell called B lymphocytes. It accounts for about 2 percent of all leukemias. Better treatments have improved the prognosis for this disease, but the treatments may be associated with an increased risk of second cancers. To determine the risk of second cancers and to examine the causes of death among these patients, Michie Hisada, M.D., Sc.D., and colleagues at the National Cancer Institute examined the records for 3,104 patients with hairy cell leukemia who survived for at least two months after diagnosis
\ 1
\ 
abuse@discover8.com
angelfish
kavin
jane2007
addict
β-Casomorphin is an opioid peptide. It was first isolat ...
www.genscript.com
Galanin, human
Galanin is a neuropeptide that has not been established as a ...
www.genscript.com
pRNATin-H1.4/Lenti
A synthetic peptide corresponding to residues 410 through 41 ...
www.genscript.com
Goat Anti-GAPDH (polyclonal)
This polyclonal antibody is highly purified from goat antise ...
www.genscript.com